Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
5 pending office actions • 3 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Haleon UK Ip Limited has 5 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 5 pending office actions are distributed across 4 distinct examiners and 3 distinct art units. This distribution shows a level of concentration, as the number of examiners is nearly equal to the number of pending actions, while the art units are more consolidated. For a practitioner, this requires managing four unique examiner relationships across 3 distinct art units.
The busiest examiner, GOTTSCHALK, DARCEY E, is currently managing 2 busiest examiner pending actions. This represents a higher concentration of work compared to the other distinct examiners who share the remaining actions. For a practitioner, the decisions made by GOTTSCHALK, DARCEY E will have a larger impact on the portfolio than any other single examiner. Managing these 5 pending office actions requires navigating the specific standards of 3 distinct art units, with a particular focus on the 2 busiest examiner pending actions assigned to the busiest examiner. Success in the Biotechnology & Pharmaceuticals area depends on the independent outcomes of these matters.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §112 only | 2 (40%) |
| Multi-statute (no §101) | 1 (20%) |
| No statute on record | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GOTTSCHALK, DARCEY E | 2 | 89.6% | +3.6% |
| STEVENS, MARK V | 1 | 65.5% | +41.6% |
| SPAMER, DONALD R | 1 | 59.2% | +32.1% |
| FALLOWAY, WILLIAM A | 1 | 92.6% | +6.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 35524873 | Cap for toothpaste tube | GOTTSCHALK, DARCEY E | 18d overdue |
| 35524862 | Cap for toothpaste tube | GOTTSCHALK, DARCEY E | 18d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18998184 | NOVEL DENTIFRICE | STEVENS, MARK V | — |
| 18853892 | DENTAL APPLIANCE CLEANSER | SPAMER, DONALD R | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18998184 | NOVEL DENTIFRICE | STEVENS, MARK V | — |
| 18853892 | DENTAL APPLIANCE CLEANSER | SPAMER, DONALD R | — |
| Art Unit | Apps |
|---|---|
| 2922 | 2 |
| 1613 | 1 |
| 2923 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18998184 | NOVEL DENTIFRICE | STEVENS, MARK V | 1613 | §101§103§112DP | Non-Final OA | — | Pending | Jan 24, 2025 |
| 18853892 | DENTAL APPLIANCE CLEANSER | SPAMER, DONALD R | — | §102§103§112Other | Non-Final OA | — | Pending | Oct 03, 2024 |
| 35524817 | Toothpaste tube | FALLOWAY, WILLIAM A | 2923 | Other | Final Rejection | — | Pending | Apr 22, 2024 |
| 35524873 | Cap for toothpaste tube | GOTTSCHALK, DARCEY E | 2922 | §112 | Non-Final OA | 18d overdue | Pending | Apr 22, 2024 |
| 35524862 | Cap for toothpaste tube | GOTTSCHALK, DARCEY E | 2922 | §112 | Non-Final OA | 18d overdue | Pending | Apr 22, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHaleon UK Ip Limited has 5 pending office actions as of October 2026, spread across 3 art units and 4 examiners.
Darcey E Gottschalk has the most, with 2 of Haleon UK Ip Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.